Obesity disrupts molecular NO signaling through oxidative stress, inflammation, and endothelial dysfunction, impairing endothelial nitric oxide synthase (eNOS) activity and lowering NO bioavailability. The gene discussed is NOS3; the disease is obesity disorder.